de Boer, S. M., Powell, M. E., Mileshkin, L., Katsaros, D., Bessette, P., Haie-Meder, C., . . . Creutzberg, C. L. (2018). Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): Final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol.
Citação norma Chicagode Boer, Stephanie M., et al. "Adjuvant Chemoradiotherapy Versus Radiotherapy Alone for Women With High-risk Endometrial Cancer (PORTEC-3): Final Results of an International, Open-label, Multicentre, Randomised, Phase 3 Trial." Lancet Oncol 2018.
Citação norma MLAde Boer, Stephanie M., et al. "Adjuvant Chemoradiotherapy Versus Radiotherapy Alone for Women With High-risk Endometrial Cancer (PORTEC-3): Final Results of an International, Open-label, Multicentre, Randomised, Phase 3 Trial." Lancet Oncol 2018.